Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanye Tablets for Impaired Glucose Tolerance
CTR20171066Phase 2Active
- Sponsor
- Tianjin University of Traditional Chinese Medicine
- Start
- Sep 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Sanye Tongzhiqing Tablets in prediabetes, type 2 diabetes mellitus (T2DM), sponsored by Tianjin University of Traditional Chinese Medicine. Started Sep 2017; status: active.
02
Drugs
Sanye Tongzhiqing Tablets
03
Conditions
prediabetestype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20171066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171066.